You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Washington Post reports on efforts to study human stem cells in microgravity.
California voters have approved additional funding for the California Institute for Regenerative Medicine, according to the Associated Press.
A new survey in Stem Cell Reports finds the majority of Americans say they could accept human-animal chimera embryos.
The acquisition will give Curi access to Dana's portfolio of artificial intelligence and machine learning technologies for in vitro cell-based assays.
The results suggest patients receiving stem cell transplants for blood cancers may be at increased risk of somatic mutation-related complications even with young bone marrow donors.
The assets include intellectual property relevant to iPSC-based phenotypic drug discovery and an existing product business around iPSC-derived cells.
The partners will offer drug discovery services based on human induced pluripotent stem cells and cells derived from these.
Researchers characterized new and known cell populations with single-cell transcriptome profiles for nearly 10,400 liver cells, using the data to see changes associated with liver cancer.
The California Institute for Regenerative Medicine is running out of funding, according to ScienceInsider.
Using CRISPR mouse and iPS cell models, the researchers showed that a rare maternally inherited variant is a genetic modifier of two paternally inherited variants.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.